drospirenone has been researched along with Atypical Endometrial Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genazzani, AR; Gerlinger, C; Gude, K; Schaefers, M; Schmelter, T | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Whitehead, M | 1 |
2 review(s) available for drospirenone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data.
Topics: Aged; Androstenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endometrial Hyperplasia; Estradiol; Female; Follow-Up Studies; Hormone Replacement Therapy; Humans; Menopause; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; United Kingdom | 2006 |
1 trial(s) available for drospirenone and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17β-estradiol in postmenopausal women.
Topics: Adult; Aged; Androstenes; Biopsy; Double-Blind Method; Drug Therapy, Combination; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Postmenopause; Treatment Outcome; Uterine Hemorrhage | 2013 |